While acute hepatitis B infection is often resolved by the immune system, CHB occurs when the body's defences are unable to ...
Aligos Therapeutics is a clinical-stage biotechnology company focused on improving patient outcomes through best-in-class ...
CD163 might not be the most exciting name in the world, but behind it lies one of the body's most important defense receptors ...
Six years before the start of the COVID-19 pandemic, an Ebola outbreak in West Africa had people fearing the possibility of a ...
Announced first in vivo clinical validation for ARCUS gene editing across two distinct programs including wholly owned PBGENE-HBV and partnered program ECUR-506 - - Commenced Phase 1 ELIMINATE-B ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results